PRIVILEGED AND CONFIDENTIAL ATTORNEY WORK PRODUCT
CALDERWOOD & HARKNESS LLP Attorneys at Law 7 Times Square New York, New York 10036 Tel: (212) 558-4000
April 15, 2025
MEMORANDUM
TO: Philip Navarro, Managing Director Ashbury Risk Advisors LLC 175 Water Street, 20th Floor New York, New York 10038
FROM: James Prentice, Partner, and Ryan Kowalski, Associate Calderwood & Harkness LLP
RE: Representations and Warranties Insurance Application — Acquisition of Luminex Systems Holdings Inc. by Ardent Apex Holdings Inc.
Matter No.: 1001-00004
Right-click to update Table of Contents
I. Introduction and Purpose
Calderwood & Harkness LLP ("Calderwood & Harkness" or the "Firm") represents Ardent Capital Partners III LP ("Ardent Capital," "Ardent," or the "Buyer") in connection with the proposed acquisition (the "Transaction" or the "Acquisition") of Luminex Systems Holdings Inc. (the "Company," the "Target," or "Luminex Holdings") for an aggregate equity value of Two Billion Eight Hundred Million Dollars ($2,800,000,000) (the "Purchase Price"). The Transaction is to be effected through a reverse triangular merger pursuant to an Agreement and Plan of Merger dated March 24, 2025 (the "Merger Agreement"), as more fully described herein.
The purpose of this memorandum (the "Memorandum") is to provide Ashbury Risk Advisors LLC ("Ashbury" or the "Broker") with a comprehensive summary of the Transaction structure, the parties involved, the due diligence conducted by Calderwood & Harkness and other advisors on behalf of the Buyer, and the key risk areas relevant to the placement of a buy-side representations and warranties insurance policy (the "R&W Policy" or the "Policy") in connection with the Acquisition. This Memorandum is intended to support Ashbury's placement of the R&W Policy with Grandview Specialty Insurance Company ("Grandview") or such other qualified insurance carrier or carriers as Ashbury may recommend.
We are requesting that Ashbury seek placement of the R&W Policy with Grandview as the preferred primary carrier, with a policy limit of $420,000,000, corresponding to the indemnification cap established in the Merger Agreement. To the extent Grandview is unable to provide the full $420,000,000 tower on terms acceptable to the Buyer, we are open to alternative primary or excess carrier proposals, and we look to Ashbury for guidance on structuring an appropriate insurance tower.
The Calderwood & Harkness engagement team for this matter consists of the following attorneys:
• James Prentice — Responsible Partner, Mergers & Acquisitions
• Sandra Tung — Billing Partner, Mergers & Acquisitions
• Ryan Kowalski — Lead Associate, Mergers & Acquisitions
• Megan Chu — Working Associate, Mergers & Acquisitions
• Sylvia Hartwell — Specialist Partner, Tax
• Elaine Forsythe — Specialist Partner, Antitrust & Competition
This Memorandum should be read in conjunction with the enclosed documents listed in Section XI below and, upon execution of an appropriate non-disclosure agreement by the underwriter, the contents of the virtual data room maintained in connection with the Transaction.
II. Transaction Overview
A. Parties. The principal parties to the Transaction are as follows:
Buyer. Ardent Capital Partners III LP is a Delaware limited partnership headquartered at 399 Park Avenue, 42nd Floor, New York, New York 10022. Ardent Capital Partners III LP is the third flagship private equity fund managed by the Ardent Capital Partners platform, with total committed capital of approximately $12.5 billion (vintage 2023). The Ardent Capital platform manages approximately $31.4 billion in aggregate assets under management across its various fund vehicles, including prior vintage flagship funds, co-investment vehicles, and continuation vehicles. The general partner of Ardent Capital Partners III LP is Ardent Capital GP III LLC, a Delaware limited liability company. The Ardent Capital platform was co-founded by, and continues to be managed by, Theodore "Ted" Hargrove and Victoria Langford, each serving as Co-Founder and Managing Partner. The investment committee of Ardent Capital Partners III LP consists of Ted Hargrove, Victoria Langford, Marcus Ellison, Priya Chandrasekaran, and David Ng. The investment committee unanimously approved the Transaction at its meeting on March 20, 2025.
Parent / Intermediate Holdco. Ardent Apex Holdings Inc. ("Apex Holdings" or the "Parent") is a Delaware corporation incorporated on March 5, 2025, solely for the purpose of effecting the Transaction. Apex Holdings is a wholly owned subsidiary of Ardent Capital Partners III LP and serves as the direct parent of the Merger Sub (as defined below). The registered agent for Apex Holdings is National Registered Agents of Delaware, Inc., located at 160 Greentree Drive, Suite 101, Dover, Delaware 19904. Apex Holdings has no assets, liabilities, or operations other than those related to the Transaction, the financing thereof, and the arrangements described in this Memorandum.
Merger Sub. Ardent Apex Merger Sub Inc. (the "Merger Sub") is a Delaware corporation incorporated on March 7, 2025, as a wholly owned subsidiary of Apex Holdings. Merger Sub was formed exclusively to effect the reverse triangular merger contemplated by the Merger Agreement. The Merger Sub has no assets, liabilities, or operations other than those related to the Transaction. Its registered agent is National Registered Agents of Delaware, Inc., at the same address as Apex Holdings. Upon consummation of the merger, Merger Sub will merge with and into Luminex Holdings, with Luminex Holdings surviving as a wholly owned subsidiary of Apex Holdings, and Merger Sub will thereupon cease to exist.
Target (Merger Target). Luminex Systems Holdings Inc. is a Delaware corporation incorporated on June 14, 2021. Luminex Holdings serves as the intermediate United States holding company for the worldwide operations of the Luminex Systems enterprise software business. The principal executive offices of Luminex Holdings are located at 2100 Reston Gateway Drive, Suite 800, Reston, Virginia 20191. The registered agent for Luminex Holdings is Capitol Corporate Services, Inc., located at 1675 South Ashbury Asset Advisors, Suite B, Dover, Delaware 19901. Luminex Holdings' Employer Identification Number is 86-2547193. The Company was incorporated in connection with a 2021 reorganization (discussed further in Section V.B below) pursuant to which the previously existing Swiss parent entity, Luminex Systems AG, became a subsidiary of the Delaware holding company.
Ultimate Target Parent. Luminex Systems AG is a Swiss Aktiengesellschaft registered in the Canton of Glenrock Assurance under Commercial Register Number CHE-284.391.057 and headquartered at Bahnhofstrasse 71, 8001 Zürich, Switzerland. Luminex Systems AG was founded in 2009 and served as the ultimate parent company of the Luminex group prior to the 2021 reorganization. Following the 2021 reorganization, Luminex AG became a subsidiary of Luminex Holdings. The current officers of Luminex AG include: Dr. Stefan Kessler, Chief Executive Officer; Annelise Gruber, Chief Financial Officer; and Roland Merz, Chairman of the Board of Directors.
Target Subsidiaries. The following entities are direct or indirect subsidiaries of Luminex Holdings and together with Luminex Holdings and Luminex AG constitute the operating group (collectively, the "Luminex Group"):
• Luminex Systems Inc. — A Delaware corporation headquartered at 2100 Reston Gateway Drive, Suite 800, Reston, Virginia 20191; Employer Identification Number 86-2547210. Luminex Systems Inc. is the principal U.S. operating subsidiary of the Luminex Group and employs the substantial majority of the Company's U.S.-based workforce. Luminex Systems Inc. holds the U.S. government contracts described in Section V.D below.
• Luminex Systems UK Ltd. — A private limited company incorporated in England and Wales under Company Number 12847362, with its registered office at 14 Broadwick Street, London W1F 8HN, United Kingdom. Luminex UK serves as the operating entity for the Company's United Kingdom and Nordic operations.
• Luminex Systems GmbH — A German limited liability company (Gesellschaft mit beschränkter Haftung) registered under HRB 247891 with the Commercial Register of the Local Court (Amtsgericht) of Munich, with its registered office at Leopoldstrasse 120, 80802 Munich, Germany. Veltronix GmbH serves as the operating entity for the Company's DACH region operations (excluding Switzerland) and employs the Company's German workforce, which is subject to a works council (Betriebsrat) arrangement.
• Luminex Systems Pte. Ltd. — A private company limited by shares incorporated in Singapore under Unique Entity Number 201924781K, with its registered office at 8 Marina Boulevard, #36-01, Singapore 018981. Luminex Singapore serves as the operating entity for the Company's Asia-Pacific operations.
Selling Stockholders. The stockholders of Luminex Holdings who will receive merger consideration (other than rollover equity) in connection with the Transaction consist of the following:
• Ridgeline Growth Equity Fund II LP — A Delaware limited partnership with its principal offices at 200 Clarendon Street, 52nd Floor, Boston, Massachusetts 02116. Ridgeline Growth Equity Fund II LP is a $6.8 billion growth equity fund (vintage 2018) managed by Ridgeline Growth Equity Partners LLC. The Managing Partner is Jonathan Ashford. Ridgeline holds approximately 52% of Luminex Holdings on a fully diluted basis and is expected to receive aggregate merger consideration of approximately $1,456,000,000 in connection with the Transaction.
• Meridian Venture Partners IV LP — A Delaware limited partnership with its principal offices at 600 Montgomery Street, Suite 2800, San Francisco, California 94111. Meridian Venture Partners IV LP is a $2.1 billion venture capital fund (vintage 2016) managed by Meridian Venture Partners Management LLC. The Managing Partner is Claire Fujimoto. Meridian holds approximately 20% of Luminex Holdings on a fully diluted basis and is expected to receive aggregate merger consideration of approximately $560,000,000 in connection with the Transaction.
• Management and Employees — Various members of the Company's management team and employees hold, in the aggregate, approximately 28% of Luminex Holdings on a fully diluted basis (including shares, vested and unvested options, and restricted stock units). The total merger consideration allocable to management and employees is approximately $784,000,000 in the aggregate, of which approximately $405,020,000 will be reinvested as rollover equity and approximately $378,980,000 will be received as cash merger consideration. See Section II.D below for a detailed breakdown of the management rollover.
B. Deal Structure
The Transaction is structured as a reverse triangular merger in which Ardent Apex Merger Sub Inc. will merge with and into Luminex Systems Holdings Inc. (the "Merger"), with Luminex Holdings surviving the Merger as a wholly owned subsidiary of Ardent Apex Holdings Inc. The surviving corporation will continue to operate the Luminex business following the closing. The Merger is governed by the Delaware General Corporation Law (the "DGCL"), and the organizational documents of the surviving corporation will be amended and restated in connection with the closing to reflect the post-closing governance arrangements agreed upon between the Buyer and the rollover management team.
The Transaction is structured as an all-cash acquisition with respect to the selling stockholders (other than the rollover participants). Each share of common stock of Luminex Holdings outstanding immediately prior to the effective time of the Merger (other than shares held by rollover participants with respect to their rollover shares, dissenting shares, and shares held by Luminex Holdings as treasury shares) will be converted into the right to receive cash merger consideration equal to $20.00 per share (the "Per-Share Merger Consideration"), calculated on the basis of the aggregate equity value of $2,800,000,000 divided by 140,000,000 fully diluted shares of Luminex Holdings. Stock options and restricted stock units outstanding under the Company's equity incentive plans will be treated in accordance with the terms of the Merger Agreement, with holders receiving the Per-Share Merger Consideration less the applicable exercise price, if any, in respect of each such award.
The Merger constitutes a change of control under numerous existing contractual arrangements of the Target and its subsidiaries, including certain customer contracts, the Company's existing senior credit agreement, employment agreements with key executives, and the Company's equity incentive plans. The change of control implications for each category of agreement have been analyzed as part of the due diligence process and are discussed in the relevant sections of this Memorandum.
C. Key Deal Terms
The principal terms of the Merger Agreement, executed on March 24, 2025, include the following:
Indemnification Cap. The aggregate indemnification cap under the Merger Agreement is $420,000,000, representing 15% of the aggregate equity value of $2,800,000,000. The R&W Policy limit is requested to mirror this cap.
Survival Periods. The representations and warranties contained in the Merger Agreement survive the closing for the following periods:
• General Representations and Warranties: Eighteen (18) months from the closing date.
• Fundamental Representations: Thirty-six (36) months from the closing date. Fundamental representations include organization, authority, capitalization, and no-conflict representations.
• Tax Representations: Sixty (60) days after the expiration of the applicable statute of limitations (including any extensions or waivers thereof).
No-Shop Provision. The Merger Agreement contains a customary no-solicitation covenant restricting the Target and its representatives from soliciting, initiating, or knowingly encouraging alternative acquisition proposals. The no-shop provision includes a fiduciary-out exception permitting the Target's board of directors to engage with an unsolicited superior proposal, subject to a four (4) business-day matching right in favor of the Buyer.
Termination Fees. The Merger Agreement provides for the following termination fee arrangements:
• Reverse Termination Fee (Buyer): $140,000,000 (5% of deal value), payable by the Buyer in the event the Merger Agreement is terminated under certain specified circumstances, including failure to obtain required regulatory approvals or breach by the Buyer of its obligations to consummate the Transaction.
• Target Termination Fee: $84,000,000 (3% of deal value), payable by the Target in the event the Merger Agreement is terminated under certain specified circumstances, including the Target's board of directors changing its recommendation in favor of a superior proposal or the Target entering into an alternative transaction within twelve months of termination.
Outside Date. The outside date for consummation of the Transaction is September 10, 2025, subject to automatic extension to December 10, 2025 if the sole unsatisfied closing condition at the initial outside date is the receipt of required regulatory approvals.
Escrow. An amount equal to $140,000,000 (5% of deal value) will be deposited into escrow at closing with Continental Fiduciary Trust Company (Account Reference: CFT-ESC-2025-7894) and held for a period of eighteen (18) months following the closing. The escrow fund serves as security for the selling stockholders' indemnification obligations under the Merger Agreement, including their share of the retention under the R&W Policy.
Working Capital Adjustment. The Merger Agreement provides for a post-closing working capital adjustment based on a target net working capital of $48,500,000, with a collar of plus or minus $2,500,000 (i.e., no adjustment will be made if the actual closing net working capital falls within the range of $46,000,000 to $51,000,000). The post-closing true-up is to be completed within ninety (90) calendar days following the closing date. In the event of any dispute regarding the working capital calculation, such dispute will be submitted to Pendleton & Associates LLP as the independent accounting firm for final and binding resolution.
Material Adverse Effect. The Merger Agreement defines "Material Adverse Effect" in a manner consistent with customary market practice, including carve-outs for: (i) changes in general economic or market conditions; (ii) changes affecting the enterprise software industry generally; (iii) changes in applicable law; (iv) effects of COVID-19 or any other pandemic or epidemic; and (v) changes in GAAP or other applicable accounting standards. Each of the foregoing carve-outs is subject to an exception to the extent such changes, effects, or conditions disproportionately affect the Target and its subsidiaries relative to other similarly situated companies in the enterprise software industry.
D. Management Rollover
A significant component of the Transaction involves the rollover of equity by key members of the Company's management team, who will reinvest a portion of their merger consideration into equity of Apex Holdings (or a subsidiary thereof designated by the Buyer). The management rollover is designed to align the interests of continuing management with those of the Buyer following the closing and is a condition to the Buyer's obligation to consummate the Transaction. The following summarizes the rollover arrangements for the principal members of management:
New employment agreements and equity incentive arrangements for Dr. Kessler, Ms. Gruber, and Dr. Vogt are currently being negotiated in connection with the closing and will include customary non-competition, non-solicitation, and vesting provisions. The aggregate rollover amount of approximately $405,020,000 represents approximately 14.5% of the total sources of funds for the Transaction.
E. Valuation Metrics
The Transaction values Luminex Holdings at an aggregate equity value of $2,800,000,000. The following table summarizes the key valuation metrics for the Target based on its fiscal year 2024 financial performance:
The Company's revenue is distributed across the following key geographic markets: DACH region (approximately 35% of total revenue), North America (approximately 40%), United Kingdom and Nordics (approximately 15%), and Asia-Pacific (approximately 10%). The enterprise value multiple of 5.75x 2024 revenue and 22.99x 2024 Adjusted EBITDA is broadly consistent with comparable transactions in the enterprise SaaS sector, reflecting the Company's strong recurring revenue profile, high gross margins, and significant market position in the procurement automation and ERP verticals.
III. Requested Policy Terms
A. Policy Structure
The Buyer is requesting the placement of a buy-side representations and warranties insurance policy in connection with the Acquisition. The Policy would provide the Buyer with insurance coverage for losses arising from breaches of the representations and warranties made by the selling stockholders and the Company in the Merger Agreement, subject to the terms, conditions, and exclusions negotiated with the carrier.
The named insured under the Policy should be Ardent Apex Holdings Inc. and its affiliates, including (without limitation) Ardent Capital Partners III LP, Ardent Apex Merger Sub Inc., and the surviving corporation following the Merger (i.e., Luminex Systems Holdings Inc. as the surviving entity). We request that the definition of "insured" be drafted broadly to capture the full Buyer group and the post-closing operating entities that may suffer losses as a result of breaches of the Merger Agreement representations.
B. Policy Limit
The requested aggregate limit of liability under the Policy is $420,000,000. This amount is equal to the indemnification cap of 15% of the aggregate equity value of $2,800,000,000, as established in the Merger Agreement. The Policy limit is intended to mirror the maximum indemnification exposure of the selling stockholders under the Merger Agreement, thereby providing the Buyer with a direct insurance recovery mechanism for the full scope of potential representation and warranty breach claims up to the contractual cap.
If a single carrier is unable to provide the full $420,000,000 limit, the Buyer is open to structuring the R&W insurance tower with one or more excess carriers, and we defer to Ashbury's judgment on the most efficient and cost-effective tower structure available in the current market.
C. Retention. The total retention under the Policy is proposed at $14,000,000, representing 0.5% of the aggregate equity value ($2,800,000,000 × 0.5%). The retention is to be shared equally between the selling stockholders and the Buyer, as follows:
• Seller's share of retention: $7,000,000 (50%)
• Buyer's share of retention: $7,000,000 (50%)
The seller's share of the retention is backstopped by the escrow fund of $140,000,000 established under the Merger Agreement. Given that the escrow fund is substantially in excess of the seller's retention amount, we do not anticipate any collectability issues with respect to the seller's portion of the retention. The escrow fund also provides security for other indemnification obligations of the selling stockholders outside the R&W Policy framework.
We note that the 0.5% retention level is consistent with current market practice for transactions in this size range and reflects the comprehensive nature of the due diligence conducted by the Buyer and its advisors.
D. Estimated Premium
Based on preliminary discussions with Ashbury and current market intelligence regarding rate-on-line for R&W policies in the technology/SaaS sector, the estimated premium for the Policy is approximately $8,400,000, calculated on the basis of an estimated rate of 2.0% on the $420,000,000 policy limit. The premium is to be paid by the Buyer at or prior to the closing of the Transaction. This estimate is subject to adjustment based on the final terms negotiated with the carrier, the scope of any exclusions, and the carrier's underwriting assessment of the risk profile of the Transaction.
E. Coverage Period
We request that the coverage periods under the Policy be aligned with the survival periods set forth in the Merger Agreement, as follows:
• General Representations and Warranties: Eighteen (18) months from the closing date, coterminous with the survival period under the Merger Agreement.
• Fundamental Representations: Thirty-six (36) months from the closing date, consistent with the extended survival period for fundamental representations under the Merger Agreement.
• Tax Representations: Coverage extending until sixty (60) days after the expiration of the applicable statute of limitations (including any extensions or waivers thereof), matching the tax representation survival period in the Merger Agreement.
Alignment of the Policy coverage periods with the Merger Agreement survival periods is critical to ensuring seamless coverage and avoiding gaps between the Buyer's contractual indemnification rights and its insurance protection.
F. Preferred Carrier
The Buyer's preferred carrier for the primary layer of the R&W Policy is Grandview Specialty Insurance Company, a Connecticut-domiciled insurance company. Grandview has been identified by Ashbury as a well-capitalized and experienced R&W insurance underwriter with a strong track record in the technology and private equity sectors. We are, however, open to alternative carrier proposals or excess layer placements to the extent Grandview is unable to provide the full $420,000,000 tower on terms and conditions acceptable to the Buyer.
IV. Sources and Uses Summary
A. Sources of Funds
The following table summarizes the sources of funds for the Transaction:
We note that the management rollover equity of $405,020,000 is a non-cash source, reflecting the reinvestment by management of a portion of their merger consideration into equity of the post-closing entity rather than a new cash contribution.
B. Uses of Funds
The following table summarizes the anticipated uses of funds for the Transaction:
The slight variance between total sources and total uses reflects rounding and the anticipated availability of cash on the Company's balance sheet at closing to fund a portion of the transaction expenses. The final sources and uses will be trued up in connection with the closing based on actual closing date balances, working capital adjustments, and final expense tallies.
C. Financing Summary
Senior Secured Credit Facility. The senior secured credit facility consists of an aggregate commitment of $1,400,000,000, comprising: (i) a $1,200,000,000 Term Loan B facility; and (ii) a $200,000,000 revolving credit facility (undrawn at closing). The lead arranger and administrative agent for the senior secured credit facility is Stonebridge Credit Partners LLC (principal contact: Nathan Ostrowski), with the following syndicate composition:
• Stonebridge Credit Partners LLC — $600,000,000 hold (lead arranger / administrative agent)
• Birchwood Capital Finance LLC — $350,000,000 hold (principal contact: Diane Pritchard)
• Ironvale Credit Fund III LP — $250,000,000 hold (principal contact: Robert Tannenbaum)
The principal terms of the Term Loan B facility include: a floating interest rate of SOFR plus 475 basis points; a seven (7) year maturity; an original issue discount ("OID") of 1.00%; annual amortization of 1% of the original principal amount; and a first-priority security interest in substantially all assets of Luminex Holdings and its domestic subsidiaries, together with a 65% pledge of the equity interests of each first-tier foreign subsidiary. The revolving credit facility bears interest at SOFR plus 425 basis points, matures in five (5) years, and includes a springing financial maintenance covenant requiring first-lien net leverage of no greater than 6.50x, which is tested only when outstanding revolving loans exceed 40% of commitments ($80,000,000).
Subordinated Notes. Crestline Mezzanine Partners II LP (principal contact: Vanessa Hartley) has committed to provide $300,000,000 in subordinated notes. The subordinated notes bear a coupon of 11.5% with a PIK toggle feature, mature in eight (8) years, and include 2.0% warrant coverage on the equity of Apex Holdings. The subordinated notes are contractually subordinated to the senior secured credit facility pursuant to an intercreditor agreement to be executed at closing.
Equity Co-Investors. The Buyer has arranged equity co-investment commitments from two institutional co-investors: Northvale Sovereign Holdings Ltd. (principal contact: Ahmad Al-Rashid), which has committed $200,000,000, and Summit Ridge Capital Partners LP (principal contact: Karen Lindstrom), which has committed $100,000,000. These co-investment commitments are documented alongside the fund commitment and are subject to customary conditions to funding.
Commitment Letter. The debt commitment letter was executed on March 8, 2025 (Reference No. SC-2025-0312-AC) and provides for committed financing on the terms summarized above, subject to customary conditions precedent including the execution of the Merger Agreement (which has now been satisfied), the absence of a Material Adverse Effect, the accuracy of specified representations and warranties, and the delivery of required financial statements and solvency certificates. A copy of the commitment letter is included among the enclosed documents.
V. Target Business Description
A. Overview. Luminex Systems AG is a Swiss-headquartered enterprise software-as-a-service ("SaaS") company founded in 2009 by Dr. Stefan Kessler and Dr. Markus Vogt. The Company develops, markets, and supports a cloud-based enterprise resource planning ("ERP"), procurement automation, and supply-chain analytics platform marketed under the brand name "Luminex One." The Luminex One platform serves mid-market and large enterprise customers across a broad range of industries, with particular strength in manufacturing, logistics, and industrial distribution verticals. The platform integrates procurement workflow automation, spend analytics, supplier management, inventory optimization, and ERP functionality into a unified cloud-native architecture.
The Company's operations span four principal geographic markets: the DACH region (Germany, Austria, and Switzerland), which accounts for approximately 35% of total revenue; North America, accounting for approximately 40% of total revenue; the United Kingdom and Nordic countries, accounting for approximately 15% of total revenue; and Asia-Pacific, accounting for approximately 10% of total revenue. The Company employs approximately 4,200 individuals globally, of whom approximately 1,650 are employed in the United States through the Company's U.S. operating subsidiary, Luminex Systems Inc.
For fiscal year 2024, the Company reported total revenue of $487,000,000, of which $441,000,000 constituted annual recurring revenue ("ARR") from software subscriptions and $46,000,000 constituted professional services revenue from implementation, training, and consulting engagements. The Company's U.S. subsidiary, Luminex Systems Inc., contributed approximately $194,800,000 of the total revenue. The Company's 2024 Adjusted EBITDA was $121,800,000, reflecting a margin of approximately 25.0%. The Company's revenue growth, strong recurring revenue characteristics, and expanding margins are key drivers of the premium valuation multiples described in Section II.E above.
B. Corporate Structure
The current corporate structure of the Luminex Group reflects a reorganization completed in 2021 (the "2021 Reorganization" or the "Inversion"). Prior to the 2021 Reorganization, Luminex Systems AG (Switzerland) served as the ultimate parent company of the Luminex Group. In connection with the 2021 Reorganization, Luminex Systems Holdings Inc. was incorporated in Delaware on June 14, 2021, and a share exchange was effected pursuant to which the shareholders of Luminex AG exchanged their shares in Luminex AG for newly issued shares of Luminex Holdings on a 1:1 basis. As a result of the share exchange, Luminex Holdings became the new ultimate parent entity of the Luminex Group, and Luminex AG became a direct or indirect subsidiary of Luminex Holdings.
The 2021 Reorganization was driven by a combination of capital markets, governance, and tax planning considerations, including the desire to establish a Delaware-incorporated parent entity to facilitate access to U.S. capital markets and private equity investors, the preference of institutional investors for a U.S.-domiciled holding structure, and certain tax planning objectives related to the utilization of the Company's intellectual property and intercompany licensing arrangements.
Following the 2021 Reorganization, the corporate structure of the Luminex Group is as follows (simplified):
1. Luminex Systems Holdings Inc. (Delaware) — Ultimate parent / U.S. holding company
2. Luminex Systems AG (Switzerland, CHE-284.391.057) — Swiss operating entity (now a subsidiary)
3. Luminex Systems Inc. (Delaware, EIN 86-2547210) — U.S. operating subsidiary
4. Luminex Systems UK Ltd. (England and Wales, Company No. 12847362) — UK operating subsidiary
5. Luminex Systems GmbH (Germany, HRB 247891 Munich) — German operating subsidiary
6. Luminex Systems Pte. Ltd. (Singapore, UEN 201924781K) — Singapore operating subsidiary
An organizational chart of the Luminex Group is included among the enclosed documents.
C. Pre-Deal Ownership
Prior to the execution of the Merger Agreement, the equity of Luminex Systems Holdings Inc. was held as follows:
• Ridgeline Growth Equity Fund II LP: Approximately 52% on a fully diluted basis. Ridgeline is a $6.8 billion growth equity fund (vintage 2018) managed by Ridgeline Growth Equity Partners LLC and led by Managing Partner Jonathan Ashford. Ridgeline originally invested in Luminex AG in 2018 through a combination of primary and secondary transactions, and its shares were exchanged into Luminex Holdings shares in connection with the 2021 Reorganization.
• Meridian Venture Partners IV LP: Approximately 20% on a fully diluted basis. Meridian is a $2.1 billion venture capital fund (vintage 2016) managed by Meridian Venture Partners Management LLC and led by Managing Partner Claire Fujimoto. Meridian was an early institutional investor in Luminex AG, having invested in the Company's Series B financing in 2015.
• Management and Employees: Approximately 28% on a fully diluted basis (aggregate), held through a combination of common shares, vested and unvested stock options, and restricted stock units granted under the Company's equity incentive plan.
D. Government Contracts
Luminex Systems Inc. (the U.S. operating subsidiary) currently holds contracts with three United States federal government agencies:
1. Department of Defense ("DOD"): Contract for a logistics software module deployed within the DOD's supply-chain management infrastructure. This contract involves the processing and management of sensitive (but unclassified) logistics data and is subject to specific security and compliance requirements.
2. Department of Energy ("DOE"): Contract for a procurement automation platform utilized by the DOE's procurement division. This contract involves integration with the DOE's internal systems and is subject to relevant cybersecurity and data-handling requirements.
3. General Services Administration ("GSA"): Enterprise license agreement for the Luminex One platform, procured through the GSA IT Schedule 70 vehicle. This contract facilitates access to the Luminex One platform by various federal civilian agencies.
These federal government contracts are significant to the Transaction for several reasons. They constitute "covered transactions" for purposes of the review by the Committee on Foreign Investment in the United States ("CFIUS"), as discussed in Section VII.B below. They also contain change of control provisions that may require consent, notification, or novation in connection with the Merger. The Buyer's antitrust and regulatory advisors have factored these contracts into the overall regulatory clearance strategy for the Transaction.
VI. Summary of Due Diligence Conducted
A. Overview of Due Diligence Process
Calderwood & Harkness, together with the Buyer's other advisors, conducted comprehensive buy-side due diligence on the Target and its subsidiaries. The due diligence process commenced upon the execution of the exclusivity agreement between the Buyer and the Target on March 12, 2025. Calderwood & Harkness prepared and delivered a detailed due diligence request list to the seller's legal counsel, Caldwell, Raines & Sheppard LLP (principal contacts: Patricia Okonkwo, Partner, and Daniel Feinberg, Senior Associate), on March 13, 2025.
The Target and its advisors established and maintained a virtual data room containing hundreds of documents responsive to the Buyer's diligence requests, including corporate organizational documents, financial statements and supporting schedules, tax returns and workpapers, material contracts, intellectual property documentation, employment records and benefit plan documents, real property leases, insurance policies, regulatory filings, and litigation records. The data room was supplemented on a rolling basis throughout the diligence period, and the Buyer's team submitted multiple rounds of supplemental information requests.
In addition to the document review, Calderwood & Harkness and the Buyer's financial and tax advisors participated in a series of management presentations and question-and-answer sessions with the Company's senior leadership team, including Dr. Stefan Kessler (CEO), Annelise Gruber (CFO), and Dr. Markus Vogt (CTO), as well as the Company's general counsel, heads of human resources, and information security officers. These sessions provided the Buyer's team with additional context regarding the Company's operations, strategic direction, regulatory posture, and risk profile.
The following subsections summarize the key areas of due diligence conducted and the principal findings in each area. Calderwood & Harkness has prepared separate, detailed due diligence summary memoranda for each major diligence workstream, which are included among the enclosed documents listed in Section XI.
B. Corporate and Organizational
Calderwood & Harkness conducted a comprehensive review of the corporate and organizational documentation of Luminex Holdings and each of its subsidiaries. The scope of this review included the following:
• Charter documents (certificates of incorporation, articles of association, memoranda of association, bylaws, and equivalent organizational documents) for each entity in the Luminex Group;
• Certificates of good standing and certificates of existence from the applicable jurisdictions of incorporation for each entity;
• Organizational charts reflecting the current corporate structure and equity ownership of the Luminex Group;
• Capitalization tables reflecting all issued and outstanding shares, options, warrants, and other equity interests of Luminex Holdings on a fully diluted basis;
• Minutes of meetings of the boards of directors, stockholders, and committees of Luminex Holdings and its subsidiaries for the period from January 1, 2022 through the present;
• Share registers and transfer records;
• Documentation relating to the 2021 Reorganization, including the share exchange agreement, tax opinions, and regulatory filings; and
• Records of qualification and registration in each jurisdiction in which the Company or its subsidiaries are authorized to transact business.
We confirmed the 2021 reorganization structure in which Luminex Systems Holdings Inc. (Delaware) became the ultimate parent entity of the Luminex Group through a 1:1 share exchange with the former shareholders of Luminex Systems AG (Switzerland). We reviewed the share exchange agreement and related tax opinions and confirmed that the exchange was effected in accordance with applicable Delaware, Swiss, and U.S. federal tax law, subject to the tax-specific analysis discussed in Section VI.D below.
We confirmed that each entity in the Luminex Group is in good standing or its equivalent in its jurisdiction of incorporation and in all jurisdictions in which it is qualified to do business. Specifically, we reviewed the following commercial register entries and confirmed their current status: CHE-284.391.057 for Luminex Systems AG; Company No. 12847362 for Luminex Systems UK Ltd.; HRB 247891 for Luminex Systems GmbH; and UEN 201924781K for Luminex Systems Pte. Ltd.
Assessment. No material issues were identified regarding the corporate organization of the Luminex Group. However, we recommend that the underwriter pay particular attention to the cross-border holding structure and the 2021 Reorganization, as any defect or challenge to the share exchange or the resulting holding structure could have implications for the Buyer's ownership of the Luminex Group post-closing.
C. Financial and Accounting
The financial due diligence of the Target was conducted by Calderwood & Harkness in coordination with the Buyer's financial advisor, Whitfield Partners LLC (Christopher Brennan), and the Buyer's tax and accounting advisor, Pendleton & Associates LLP (Richard Chow). The scope of the financial due diligence included the following:
• Review of the consolidated audited financial statements of Luminex Systems Holdings Inc. for fiscal years 2022, 2023, and 2024, each prepared in accordance with U.S. Generally Accepted Accounting Principles ("GAAP") and audited by Hargrove Thornton LLP (lead audit partner: Margaret Dawson, One Liberty Plaza, 165 Broadway, New York, New York 10006). The auditor issued unqualified audit opinions for each of the three fiscal years reviewed.
• Review of interim unaudited financial statements for the period ending February 28, 2025.
• Detailed analysis of the Company's revenue recognition policies and practices under ASC 606, Revenue from Contracts with Customers, including examination of the allocation of transaction prices among performance obligations, the timing of revenue recognition for multi-element arrangements, and the treatment of professional services and implementation revenues.
• Review of deferred revenue schedules and analysis of the Company's subscription billing and collection cycles.
• Analysis of customer churn metrics, including gross revenue churn, net revenue retention, and cohort-level performance, for the periods under review.
• Working capital analysis, including reconciliation of the target net working capital of $48,500,000 to the historical financial data and identification of seasonality, one-time items, and non-recurring adjustments.
• Review of the Company's accounting for stock-based compensation, capitalized software development costs, and other non-cash items impacting Adjusted EBITDA.
For fiscal year 2024, the Company reported total revenue of $487,000,000, annual recurring revenue of $441,000,000, and Adjusted EBITDA of $121,800,000 (a margin of approximately 25.0%). Pendleton & Associates LLP has been engaged to assist with the post-closing purchase price allocation, including the analysis of a potential Section 338(h)(10) election, as described in Section VI.D below.
Assessment. No material financial or accounting issues were identified during the course of our review. The Company's financial statements appear to have been prepared in accordance with GAAP in all material respects, and the auditor's opinions are unqualified. The working capital analysis supports the target net working capital of $48,500,000, and the ±$2,500,000 collar provides an appropriate de minimis threshold for post-closing adjustment.
D. Tax. The tax due diligence was led by Sylvia Hartwell (Calderwood & Harkness, Tax) and Richard Chow (Pendleton & Associates LLP). The tax due diligence encompassed a review of the federal, state, and international tax positions of the Target and each of its subsidiaries, with particular focus on the following areas:
Section 338(h)(10) Election. The Buyer is evaluating whether to make an election under Section 338(h)(10) of the Internal Revenue Code in connection with the Acquisition. If made, the election would treat the acquisition of Luminex Holdings as an asset acquisition for U.S. federal income tax purposes, resulting in a step-up in the tax basis of the Company's assets to their fair market value. Pendleton & Associates has estimated the tax basis step-up at approximately $620,000,000 in amortizable intangible assets, which would generate present value tax savings to the Buyer of approximately $195,000,000 over the amortization period. The final determination regarding the Section 338(h)(10) election will be made in consultation with the selling stockholders prior to closing, and the allocation of the economic costs and benefits of the election between the Buyer and the sellers is the subject of ongoing negotiation.
Swiss Withholding Tax. Switzerland imposes a statutory withholding tax of 35% on dividends and certain other distributions made by Swiss-resident companies. Under the Treaty between the United States and Switzerland for the Avoidance of Double Taxation with Respect to Taxes on Income (the "U.S.-Swiss Tax Treaty"), the withholding tax rate on dividends paid by a Swiss subsidiary to a qualifying U.S. parent corporation may be reduced to 5%, subject to satisfaction of the limitation-on-benefits provisions of the Treaty. The tax due diligence team reviewed the Company's historical withholding tax compliance and the applicability of the treaty rate to post-closing distributions from Luminex AG to the Buyer's holding structure.
Transfer Pricing. The intercompany transfer pricing arrangements within the Luminex Group were a significant area of focus during the tax due diligence. Currently, Luminex AG licenses its intellectual property to Luminex Systems Inc. (the U.S. operating subsidiary) under an intercompany licensing agreement at a royalty rate of 4.5% of U.S. net revenues. As part of the post-closing integration planning, the Buyer is considering restructuring the intercompany royalty rate to 6.0% of U.S. net revenues to reflect the anticipated post-closing allocation of functions, assets, and risks within the group. The existing transfer pricing documentation was reviewed for compliance with applicable U.S. (Section 482 and the Treasury Regulations thereunder) and OECD transfer pricing guidelines.
FIRPTA Analysis. A review was conducted to assess the applicability of the Foreign Investment in Real Property Tax Act ("FIRPTA") to the Transaction, given the cross-border nature of the Company's operations and the involvement of non-U.S. selling stockholders and management rollover participants. Based on the Company's asset composition (predominantly intangible assets and working capital, with no owned real property), the FIRPTA analysis did not identify material withholding tax exposure in connection with the Transaction.
State and Local Tax Nexus. The tax team reviewed the Company's state and local tax nexus positions across the United States, including income/franchise tax nexus, sales and use tax collection obligations, and payroll tax compliance, for each state in which the Company has employees, customers, or physical presence.
Tax Controversies. We did not identify any material unresolved tax audits, assessments, or disputes involving the Company or its subsidiaries. We note, however, that the Internal Revenue Service is currently conducting a transfer-pricing documentation review with respect to the Luminex AG-to-Luminex US intercompany licensing arrangement for the 2022 tax year. This review is in the information-gathering phase, and no proposed adjustments or deficiency notices have been issued. The Company's tax advisors characterize the review as routine, and we concur that it does not presently rise to the level of a material tax controversy. Nevertheless, we have flagged this item for the underwriter's attention.
Assessment. Tax representations in the Merger Agreement survive until sixty (60) days after the expiration of the applicable statute of limitations, providing an extended coverage window for tax-related claims. We recommend that the R&W Policy include robust coverage for the tax representations and that the underwriter specifically evaluate the Section 338(h)(10) election analysis, Swiss withholding tax structuring, and transfer pricing restructuring as areas of potential exposure.
E. Intellectual Property and Technology
Calderwood & Harkness conducted a detailed review of the Target's intellectual property portfolio and technology assets, which constitute the core value of the Luminex business. The scope of this review included:
• Patent Portfolio: Review of the Company's granted patents and pending patent applications in the United States, Europe, and other jurisdictions, relating to the Luminex One platform's core architecture, data analytics algorithms, workflow automation engines, and supply-chain optimization methodologies.
• Trademark Registrations: Review of the Company's trademark registrations for the "Luminex," "Luminex One," and related brand marks in the United States, European Union, Switzerland, and other jurisdictions.
• Domain Names: Review of the Company's portfolio of registered domain names, including luminexsystems.com and related domains.
• Trade Secrets: Review of the Company's policies and procedures for the protection of trade secrets and confidential business information, including employee confidentiality agreements, access controls, and information security protocols.
• Proprietary Software: Review of the technical architecture and documentation for the Luminex One platform, including source code management practices, version control, and disaster recovery procedures.
• Open-Source Software: Review of the Company's usage of open-source software components within the Luminex One platform and assessment of compliance with applicable open-source licenses (including GPL, LGPL, Apache, MIT, and BSD-family licenses). The review included an analysis of the Company's open-source software policy and the results of automated license scanning tools.
• Intercompany IP Licensing: Review of the intercompany intellectual property licensing arrangements between Luminex AG (as licensor) and Luminex Systems Inc. (as licensee), including the current royalty rate of 4.5% of U.S. net revenues. These intercompany arrangements are also relevant to the transfer pricing considerations discussed in Section VI.D above.
• IP Assignment and Work-for-Hire Documentation: Review of the Company's IP assignment agreements, work-for-hire agreements, and invention assignment provisions in employment agreements across all jurisdictions.
Assessment. No material intellectual property litigation is pending against the Company or its subsidiaries, and no third-party infringement claims have been asserted against the Luminex One platform. However, as is typical for companies operating in the enterprise SaaS and ERP space, there are inherent freedom-to-operate risks given the density of patent portfolios held by competitors and other market participants. We recommend that the underwriter focus particular attention on: (i) open-source license compliance, particularly with respect to any copyleft-licensed components that may be incorporated into the Luminex One platform's proprietary codebase; and (ii) the adequacy of IP assignment and work-for-hire documentation across all jurisdictions, particularly with respect to contributions from contractors and employees in non-U.S. jurisdictions where the work-for-hire doctrine may not apply.
F. Material Contracts
Calderwood & Harkness conducted a comprehensive review of the Target's material commercial contracts and other significant contractual arrangements. The scope of this review encompassed approximately 340 commercial contracts, including customer subscription agreements, enterprise license agreements, vendor and supplier contracts, partnership and channel agreements, reseller arrangements, and technology licensing agreements.
Of particular significance, we identified twenty-six (26) enterprise license agreements that contain change of control provisions requiring consent from, or notice to, the applicable counterparty in connection with the Merger. Failure to obtain such consents prior to or at closing could result in the termination or modification of certain of these agreements, or the assertion of breach claims by counterparties. The Buyer's deal team has established a consent tracker to monitor the status of all required consents and has begun the outreach process to counterparties.
We also reviewed the three U.S. federal government contracts described in Section V.D above (DOD, DOE, and GSA), each of which contains change of control and/or novation requirements that must be addressed in connection with the Transaction.
The Merger Agreement includes customary interim operating covenants that restrict the Company's ability to take certain actions between signing and closing without the Buyer's prior written consent. Key restrictions include:
• Capital expenditures in excess of $5,000,000 (individually or in the aggregate);
• New hires with an annual base salary in excess of $250,000;
• Entry into new contracts or amendment of existing contracts with aggregate commitments in excess of $2,000,000; and
• Licensing of intellectual property outside the ordinary course of business consistent with past practice.
Assessment. The material contracts review did not identify any individual contract that, if not consented to or novated in connection with the Merger, would reasonably be expected to result in a Material Adverse Effect. However, the aggregate effect of multiple counterparty terminations, if they were to occur, could be significant. We recommend that the underwriter evaluate the scope and status of the consent process as part of its underwriting analysis.
G. Employment and Benefits
Calderwood & Harkness conducted a review of the Target's employment arrangements and employee benefit programs across all jurisdictions in which the Company has employees. The scope of this review included:
• United States: Review of the Company's U.S. employee benefit plans (including its 401(k) plan, health and welfare plans, and equity incentive plan), employment offer letters, severance arrangements, and compliance with applicable federal and state employment laws. Approximately 1,650 employees are employed through Luminex Systems Inc. in the United States.
• Switzerland: Review of Swiss employment contracts, social insurance arrangements (AHV/IV/EO, BVG occupational pension, and UVG accident insurance), and collective bargaining obligations applicable to Luminex AG and its Swiss employees.
• Germany: Review of employment contracts, works council (Betriebsrat) arrangements at Veltronix GmbH, and compliance with German employment law (including the German Works Constitution Act (Betriebsverfassungsgesetz) and applicable collective bargaining agreements). The German works council will need to be informed and consulted in connection with the Transaction, and certain aspects of the post-closing integration may be subject to co-determination rights.
• United Kingdom: Review of employment contracts, pension arrangements, and compliance with UK employment law for employees of Luminex Systems UK Ltd.
• Singapore: Review of employment contracts and compliance with Singapore employment regulations (including the Employment Act and CPF contributions) for employees of Luminex Systems Pte. Ltd.
We reviewed the key executive employment agreements for Dr. Stefan Kessler (CEO), Annelise Gruber (CFO), and Dr. Markus Vogt (CTO), each of which contains change of control provisions that are triggered by the Merger. These change of control provisions include accelerated vesting of equity awards and, in certain cases, enhanced severance entitlements upon a qualifying termination of employment following a change of control. As noted in Section II.D above, new employment agreements and equity incentive arrangements for each of these executives are currently being negotiated in connection with the management rollover and post-closing governance arrangements.
We also reviewed the Company's equity incentive plan (the "Luminex Equity Incentive Plan"), under which stock options and restricted stock units have been granted to management and other employees. The treatment of outstanding awards under the Luminex Equity Incentive Plan in connection with the Merger is governed by the Merger Agreement, which provides for the conversion of vested awards into the right to receive the Per-Share Merger Consideration (less any applicable exercise price) and the rollover or cancellation of unvested awards in accordance with the negotiated arrangements for each category of participant.
Assessment. No material employment or benefits issues were identified. We recommend that the underwriter consider the change of control severance triggers, the complexity of the multi-jurisdictional workforce (particularly the German works council considerations), and the ongoing negotiations regarding the management rollover and new employment agreements as areas warranting review.
H. Litigation and Regulatory
Calderwood & Harkness conducted a review of the litigation, regulatory, and compliance posture of the Target and its subsidiaries. The scope of this review included:
• Search of federal and state court dockets, arbitration records, and administrative proceedings for any pending or threatened litigation, claims, or investigations involving the Company or its subsidiaries;
• Review of the Company's internal litigation files and legal hold records;
• Review of correspondence with regulators, including any pending or threatened governmental investigations or enforcement actions;